Target intelligence / Profile preview

60S ribosomal subunit exit site (E-site) (60S E-site)

Target
60S E-site
Molecular classification
Ribonucleoprotein complex, Ribosomal subunit
01

Overview

The 60S ribosomal subunit exit site (E-site) is a critical functional pocket within the large subunit of the eukaryotic ribosome that facilitates the release of deacylated tRNA during the elongation phase of protein synthesis (Alberts et al., 2014). As one of the three conserved tRNA binding sites, the E-site plays a vital role in maintaining the fidelity and progression of the translation machinery by coordinating with the A and P sites during the translocation of the mRNA-tRNA complex (Ben-Shem et al., 2011, Science). This site is the primary target for several potent inhibitors of eukaryotic translation, most notably the glutarimide antibiotics cycloheximide and lactimidomycin, which bind to the E-site and sterically block the movement of tRNA, thereby arresting protein production (Schneider-Poetsch et al., 2010, Nature Chemical Biology). While these inhibitors are invaluable tools in molecular biology for studying translation dynamics, their therapeutic application is limited by a lack of selectivity between human and other eukaryotic ribosomes, leading to significant systemic toxicity (Garreau de Loubresse et al., 2014, Nature). However, the E-site remains a subject of intense research for the development of selective antifungal and antiparasitic agents that can distinguish between host and pathogen ribosomal structures. Additionally, dysregulation of ribosomal function at the E-site is implicated in various ribosomopathies and certain types of cancer, where altered translation rates contribute to disease progression.

Other names
Ribosomal E-siteExit site of the large ribosomal subunitE-site of the 60S subunit80S ribosomal E-site
02

Mechanism of action

Inhibition of translation elongation by binding to the E-site and sterically hindering the release of deacylated tRNA or the translocation of the mRNA-tRNA complex (Schneider-Poetsch et al., 2010, Nature Chemical Biology).

03

Biological functions

Protein synthesisTranslation elongationtRNA releaseTranslocation
04

Disease associations

InfectionCancerRibosomopathy
05

Safety considerations

High systemic cytotoxicity due to inhibition of host protein synthesisLack of selectivity between human and other eukaryotic ribosomesActivation of the ribotoxic stress response and p53-mediated apoptosis
06

Interacting drugs

Cycloheximide

3 more in the full profile.

07

Biomarkers

Ribosomal protein L44 (uL44) expression levelsGlobal protein synthesis rateeEF2 phosphorylation status

Beyond the preview

Go deeper on 60S ribosomal subunit exit site (E-site) (60S E-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 60S ribosomal subunit exit site (E-site) (60S E-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call